CliffBio
small molecule

FLUDEOXYGLUCOSE F18

FLUDEOXYGLUCOSE F-18

Loss of exclusivity—loss of exclusivity
CompanyCARDINAL HEALTH 414 LLC CARDINAL HEALTH NUCLEAR PHARMACY SERVICES

Drug detail

Brand nameFLUDEOXYGLUCOSE F18
Active ingredientFLUDEOXYGLUCOSE F-18
Strength20-300mCi/ML
Dosage formINJECTABLE
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalNovember 2015
Marketing statusRX

More from CARDINAL HEALTH 414 LLC CARDINAL HEALTH NUCLEAR PHARMACY SERVICES

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.